See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
BioMarin Pharmaceutical Inc. (BMRN) - free report >>
Alaska Air Group, Inc. (ALK) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
BioMarin Pharmaceutical Inc. (BMRN) - free report >>
Alaska Air Group, Inc. (ALK) - free report >>
Image: Bigstock
New Strong Sell Stocks for April 16th
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Exterran Corporation is a systems and process company that offers solutions in power, water, oil and gas markets. The Zacks Consensus Estimate for its current year earnings has been revised 92.1% downward over the last 30 days.
Champions Oncology, Inc. (CSBR - Free Report) is a developer and marketer of technology solutions and products that are used to personalize the usage and development of oncology drugs. The Zacks Consensus Estimate for its current year earnings has been revised 8.3% downward over the last 30 days.
Cross Country Healthcare, Inc. (CCRN - Free Report) is a provider of healthcare staffing, recruiting and workforce solutions. The Zacks Consensus Estimate for its current year earnings has been revised 25% downward over the last 30 days.
Alaska Air Group, Inc. (ALK - Free Report) is a provider of passenger and cargo air transportation services. The Zacks Consensus Estimate for its current year earnings has been revised 3.9% downward over the last 30 days.
BioMarin Pharmaceutical Inc. (BMRN - Free Report) is a biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 8.8% downward over the last 30 days.
View the entire Zacks Rank #5 List.